Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand's goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified, and lower-risk business than a typical biotech company. Ligand business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation, and partnering. Ligand partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management, and commercialization) to ultimately generate Ligand revenue.

Guangxi Nanning Zhijian Zhifan Technology Consulting Co., Ltd., established on 2014-05-30, Business scope includes technology projects,technology development,Technology Promotion,Technology Transfer Consulting,Agricultural project investment consulting,Intellectual Property Consulting,intellectual property,Consultation on legal affairs related to patented technology,Patent Litigation Consulting,Patent agency consultation.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Xiant Technologies, Inc. designs and manufactures photon modulation lighting systems for optimizing organism growth, destruction, and repair for both poultry and plants. The company was founded by Jon Daren Suntych and Jason Stewart Suntych in 2014 and is headquartered in Greeley, CO.

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Ethyl Corporation provides chemical manufacturing and supply solutions to enhance the performance of products across diverse industries. Their more than 90 years of experience in chemical manufacturing allows Ethyl to respond to unique customer needs and gives us the ability to deliver market solutions when you need them most. Dating back to 1921, when Charles Kettering first discovered a solution to engine “knock,” and formed General Motors Chemical Corporation, to 1924 when the company became known as Ethyl Gasoline Corporation, and finally Ethyl Corporation in 1942, the company continues to focus on chemical manufacturing and distributing.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Levo Therapeutics is a biomedical research and development services intended to treat the multisystem neurodevelopmental disorder. The company's research and development services are dedicated to using genetic insights to advance treatments for Prader-Willi syndrome and related disorders, enabling patients to get cured of severe neurodevelopmental disorders.

Leptos is developing a proprietary neuromodulation therapy for chronic obesity. The treatment, delivered via a pacemaker-type device, involves electrical activation of a specific nerve in the autonomic nervous system.\nThey believe that this therapy may offer an effective minimally invasive, reversible surgical option for people suffering from chronic obesity. As yet, the Leptos therapy is not approved for sale in the United States and is limited to investigational use.

Stoller Enterprises, Inc., a subsidiary of Stoller International, Inc., is an American company located in Houston, TX, that wholesales crop health products.

Research Development Foundation is an American private company that operates as noncommercial research organizations.

Markets and distributes specialty, artisanal and farmstead cheese products

Jingyu County Landi Chinese Herbal Medicine Planting Co., Ltd., established on 2012-08-02, Business scope includes blueberries,Eleuthero,Schisandra,Chinese herbal medicine planting and sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

American Home Products LLC operates as a holding company which engages in the acquisition of niche manufacturers and distributors of functional and decorative architectural building and renovation products. These products are provided to the residential markets. The company was founded in 2014 and is headquartered in Van Nuys, CA.

Ethicon Endo-Surgery, Inc. manufactures surgical devices and equipments. Its products include the ENDOPATH XCEL access system, CONTOUR curved cutter stapler, HARMONIC ultrasonic cutting and coagulation surgical devices and the MAMMOTOME breast biopsy system. The company was founded in 1992 and is headquartered in Cincinnati, OH.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Fujian Heshengyuan Biotechnology Co., Ltd., established on 2011-06-16, Business scope includes general items:Research and development of bio-based materials technology;Sales of bio-based materials;Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Food Additive Sales;Sales of agricultural and sideline products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Production of tea products;food business(Selling prepackaged food);Health food sales;Health food production;Food additive production;Food Internet Sales(Selling prepackaged food)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Astute Medical is dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The Company's focus is on community and hospital-acquired acute conditions that require rapid diagnosis and risk assessment. The company's current areas of interest include abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury and sepsis. Founded in 2007, the company is led by Christopher Hibberd and Paul McPherson, former members of the management at Biosite Incorporated, a leading diagnostics company acquired by Inverness Medical Innovations in 2007 for $1.7 billion. Hibberd served at Biosite for 10 years, most recently as Senior Vice President Corporate Development. Dr. McPherson was at Biosite for 14 years, most recently as Vice President Research and Development.